Zur Rose Group AG Logo

Zur Rose Group AG

0RRB.L

(0.0)
Stock Price

35,02 CHF

-29.2% ROA

-32.99% ROE

-6.18x PER

Market Cap.

935.259.495,00 CHF

65.24% DER

0% Yield

-11.17% NPM

Zur Rose Group AG Stock Analysis

Zur Rose Group AG Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Zur Rose Group AG Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

6 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

7 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Zur Rose Group AG Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Zur Rose Group AG Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Zur Rose Group AG Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Zur Rose Group AG Revenue
Year Revenue Growth
2012 524.659.000
2013 915.589.000 42.7%
2014 920.385.000 0.52%
2015 838.447.000 -9.77%
2016 883.831.000 5.13%
2017 990.448.000 10.76%
2018 1.207.108.000 17.95%
2019 1.355.539.000 10.95%
2020 1.476.930.000 8.22%
2021 1.726.503.000 14.46%
2022 1.608.222.000 -7.35%
2023 925.914.000 -73.69%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Zur Rose Group AG Research and Development Expenses
Year Research and Development Expenses Growth
2012 0
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Zur Rose Group AG General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 29.390.000
2013 0 0%
2014 0 0%
2015 100.971.000 100%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Zur Rose Group AG EBITDA
Year EBITDA Growth
2012 5.469.000
2013 -545.000 1103.49%
2014 20.087.000 102.71%
2015 9.274.000 -116.59%
2016 -3.427.000 370.62%
2017 -29.158.000 88.25%
2018 -24.604.000 -18.51%
2019 -71.006.000 65.35%
2020 -115.235.000 38.38%
2021 -177.911.000 35.23%
2022 -132.436.000 -34.34%
2023 -56.270.000 -135.36%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Zur Rose Group AG Gross Profit
Year Gross Profit Growth
2012 47.196.000
2013 82.909.000 43.07%
2014 86.680.000 4.35%
2015 129.720.000 33.18%
2016 136.223.000 4.77%
2017 154.105.000 11.6%
2018 191.212.000 19.41%
2019 208.650.000 8.36%
2020 241.333.000 13.54%
2021 260.046.000 7.2%
2022 245.627.000 -5.87%
2023 199.872.000 -22.89%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Zur Rose Group AG Net Profit
Year Net Profit Growth
2012 6.142.000
2013 -15.464.000 139.72%
2014 7.154.000 316.16%
2015 3.445.000 -107.66%
2016 -12.769.000 126.98%
2017 -36.238.000 64.76%
2018 -38.971.000 7.01%
2019 -52.358.000 25.57%
2020 -135.695.000 61.41%
2021 -225.735.000 39.89%
2022 -171.115.000 -31.92%
2023 -116.480.000 -46.91%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Zur Rose Group AG Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 2
2013 -5 140%
2014 2 350%
2015 1 -100%
2016 -4 133.33%
2017 -7 50%
2018 -6 0%
2019 -6 0%
2020 -15 57.14%
2021 -23 39.13%
2022 -16 -53.33%
2023 -10 -66.67%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Zur Rose Group AG Free Cashflow
Year Free Cashflow Growth
2012 19.872.000
2013 -536.000 3807.46%
2014 284.000 288.73%
2015 12.956.000 97.81%
2016 -16.847.000 176.9%
2017 -27.310.000 38.31%
2018 -43.484.999 37.2%
2019 -92.965.000 53.22%
2020 -93.928.000 1.03%
2021 -145.252.000 35.33%
2022 -112.756.000 -28.82%
2023 -18.781.000 -500.37%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Zur Rose Group AG Operating Cashflow
Year Operating Cashflow Growth
2012 20.809.000
2013 2.004.000 -938.37%
2014 7.200.000 72.17%
2015 18.872.000 61.85%
2016 -13.830.000 236.46%
2017 -22.227.000 37.78%
2018 -33.226.999 33.11%
2019 -82.571.000 59.76%
2020 -67.511.000 -22.31%
2021 -130.631.000 48.32%
2022 -97.287.000 -34.27%
2023 -18.114.500 -437.07%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Zur Rose Group AG Capital Expenditure
Year Capital Expenditure Growth
2012 937.000
2013 2.540.000 63.11%
2014 6.916.000 63.27%
2015 5.916.000 -16.9%
2016 3.017.000 -96.09%
2017 5.083.000 40.65%
2018 10.258.000 50.45%
2019 10.394.000 1.31%
2020 26.417.000 60.65%
2021 14.621.000 -80.68%
2022 15.469.000 5.48%
2023 666.500 -2220.93%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Zur Rose Group AG Equity
Year Equity Growth
2012 86.189.000
2013 73.380.000 -17.46%
2014 77.351.000 5.13%
2015 72.776.000 -6.29%
2016 103.806.000 29.89%
2017 294.223.000 64.72%
2018 443.606.000 33.67%
2019 405.542.000 -9.39%
2020 531.741.000 23.73%
2021 484.923.000 -9.65%
2022 350.779.000 -38.24%
2023 494.064.000 29%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Zur Rose Group AG Assets
Year Assets Growth
2012 265.742.000
2013 225.112.000 -18.05%
2014 228.117.000 1.32%
2015 233.423.000 2.27%
2016 261.528.000 10.75%
2017 461.768.000 43.36%
2018 726.520.000 36.44%
2019 991.725.000 26.74%
2020 1.278.482.000 22.43%
2021 1.269.214.000 -0.73%
2022 1.099.445.000 -15.44%
2023 1.010.521.000 -8.8%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Zur Rose Group AG Liabilities
Year Liabilities Growth
2012 179.553.000
2013 151.732.000 -18.34%
2014 150.766.000 -0.64%
2015 160.647.000 6.15%
2016 157.722.000 -1.85%
2017 167.545.000 5.86%
2018 282.914.000 40.78%
2019 586.183.000 51.74%
2020 746.741.000 21.5%
2021 784.291.000 4.79%
2022 748.666.000 -4.76%
2023 516.457.000 -44.96%

Zur Rose Group AG Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
106.75
Net Income per Share
-12.26
Price to Earning Ratio
-6.18x
Price To Sales Ratio
0.75x
POCF Ratio
-9.49
PFCF Ratio
-9.19
Price to Book Ratio
1.79
EV to Sales
0.59
EV Over EBITDA
-7.56
EV to Operating CashFlow
-7.89
EV to FreeCashFlow
-7.22
Earnings Yield
-0.16
FreeCashFlow Yield
-0.11
Market Cap
0,94 Bil.
Enterprise Value
0,74 Bil.
Graham Number
108.01
Graham NetNet
-15.36

Income Statement Metrics

Net Income per Share
-12.26
Income Quality
-1.65
ROE
-0.34
Return On Assets
-0.14
Return On Capital Employed
-0.14
Net Income per EBT
0.99
EBT Per Ebit
1.18
Ebit per Revenue
-0.1
Effective Tax Rate
-0.01

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.02
Operating Profit Margin
-0.1
Pretax Profit Margin
-0.11
Net Profit Margin
-0.11

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-7.98
Free CashFlow per Share
-8.71
Capex to Operating CashFlow
0.09
Capex to Revenue
-0.01
Capex to Depreciation
-0.47
Return on Invested Capital
-0.16
Return on Tangible Assets
-0.29
Days Sales Outstanding
12.93
Days Payables Outstanding
19.87
Days of Inventory on Hand
15.59
Receivables Turnover
28.23
Payables Turnover
18.37
Inventory Turnover
23.42
Capex per Share
-0.73

Balance Sheet

Cash per Share
24,14
Book Value per Share
42,29
Tangible Book Value per Share
-2.2
Shareholders Equity per Share
42.29
Interest Debt per Share
27.59
Debt to Equity
0.65
Debt to Assets
0.32
Net Debt to EBITDA
2.05
Current Ratio
2.75
Tangible Asset Value
-0,03 Bil.
Net Current Asset Value
-0,11 Bil.
Invested Capital
0.65
Working Capital
0,26 Bil.
Intangibles to Total Assets
0.51
Average Receivables
0,04 Bil.
Average Payables
0,06 Bil.
Average Inventory
43657000
Debt to Market Cap
0.34

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Zur Rose Group AG Dividends
Year Dividends Growth
2022 0

Zur Rose Group AG Profile

About Zur Rose Group AG

Zur Rose Group AG operates an e-commerce pharmacy and a wholesale business for medical and pharmaceutical products under the Zur Rose and DocMorris brands in Germany, Switzerland, and rest of Europe. It offers consumer health, beauty, and personal care products. The company also provides medicines management services. It operates stationary pharmacy shops. The company sells its products directly to physicians, online mail-order pharmacies, and private individuals. The company was formerly known as Zur Rose AG and changed its name to Zur Rose Group AG in May 2015. Zur Rose Group AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.

CEO
Mr. Walter Hess
Employee
2.283
Address
WalzmUehlestrasse 60
Frauenfeld, 8500

Zur Rose Group AG Executives & BODs

Zur Rose Group AG Executives & BODs
# Name Age
1 Mr. Kaspar Niklaus
Chief Operating Officer & Member of Executive Board
70
2 Lisa Luthi
Head of Corporate Communications
70
3 Mr. Marcel Ziwica
Chief Financial Officer & Member of Executive Board
70
4 Mr. Madhu Nutakki
Chief Technology Officer & Member of Executive Board
70
5 Mr. David Maso
Head of Europe & Member of Executive Board
70
6 Dr. Daniel Grigat
Group Head of Investor Relations & Sustainability
70
7 Mr. Walter Oberhansli
Founder & Chairman
70
8 Mr. Walter Hess
Chief Executive Officer & Member of Executive Board
70

Zur Rose Group AG Competitors

AltynGold plc Logo
AltynGold plc

ALTN.L

(2.8)
Galenica AG Logo
Galenica AG

0ROG.L

(0.2)
Ariana Resources plc Logo
Ariana Resources plc

AAU.L

(1.8)